KALA
Price
$18.77
Change
+$0.55 (+3.02%)
Updated
Sep 26, 04:22 PM (EDT)
Capitalization
127.92M
SIGY
Price
$3.75
Change
+$0.25 (+7.14%)
Updated
Sep 24 closing price
Capitalization
6.02M
Interact to see
Advertisement

KALA vs SIGY

Header iconKALA vs SIGY Comparison
Open Charts KALA vs SIGYBanner chart's image
Kala BIO
Price$18.77
Change+$0.55 (+3.02%)
Volume$100
Capitalization127.92M
Sigyn Therapeutics
Price$3.75
Change+$0.25 (+7.14%)
Volume$2.1K
Capitalization6.02M
KALA vs SIGY Comparison Chart in %
Loading...
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KALA vs. SIGY commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a Buy and SIGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (KALA: $18.22 vs. SIGY: $3.75)
Brand notoriety: KALA and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALA: 70% vs. SIGY: 206%
Market capitalization -- KALA: $127.92M vs. SIGY: $6.02M
KALA [@Biotechnology] is valued at $127.92M. SIGY’s [@Biotechnology] market capitalization is $6.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALA’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • KALA’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, KALA is a better buy in the long-term than SIGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALA’s TA Score shows that 3 TA indicator(s) are bullish while SIGY’s TA Score has 5 bullish TA indicator(s).

  • KALA’s TA Score: 3 bullish, 5 bearish.
  • SIGY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SIGY is a better buy in the short-term than KALA.

Price Growth

KALA (@Biotechnology) experienced а +3.91% price change this week, while SIGY (@Biotechnology) price change was +7.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.34%, and the average quarterly price growth was +51.85%.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALA($128M) has a higher market cap than SIGY($6.02M). KALA YTD gains are higher at: 162.536 vs. SIGY (19.048). SIGY has higher annual earnings (EBITDA): -2.39M vs. KALA (-31.92M). KALA has more cash in the bank: 31.9M vs. SIGY (12.9K). SIGY has less debt than KALA: SIGY (2.51M) vs KALA (29.9M). KALA (0) and SIGY (0) have equivalent revenues.
KALASIGYKALA / SIGY
Capitalization128M6.02M2,126%
EBITDA-31.92M-2.39M1,335%
Gain YTD162.53619.048853%
P/E RatioN/AN/A-
Revenue00-
Total Cash31.9M12.9K247,287%
Total Debt29.9M2.51M1,190%
FUNDAMENTALS RATINGS
KALA vs SIGY: Fundamental Ratings
KALA
SIGY
OUTLOOK RATING
1..100
8694
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3445
P/E GROWTH RATING
1..100
9798
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KALA's Valuation (62) in the Pharmaceuticals Major industry is in the same range as SIGY (84) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

KALA's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SIGY (100) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

KALA's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as SIGY (100) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

KALA's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as SIGY (45) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

KALA's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as SIGY (98) in the null industry. This means that KALA’s stock grew similarly to SIGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KALASIGY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 25 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNST37.200.15
+0.40%
Renasant Corp
ENFY1.00N/A
N/A
Enlightify Inc
HAFC24.82-0.06
-0.24%
Hanmi Financial Corp
NTR58.15-0.88
-1.49%
Nutrien Ltd
PEW5.13-0.37
-6.73%
Grabagun Digital Holdings Inc

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
OTLK - SIGY
23%
Poorly correlated
-1.48%
ACHV - SIGY
21%
Poorly correlated
-3.57%
KALA - SIGY
21%
Poorly correlated
-4.78%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
-0.01%
More